Anavex Life Sciences Corp.
A2-73 as a therapeutic for insomnia, anxiety, and agitation
Last updated:
Abstract:
A2-73 is a useful therapeutic in the treatment of humans suffering from insomnia, anxiety or agitation. Particular attention is made to oral daily doses of from about 10 mg to about 50 mg, with particular reference to about 20 to 30 mg.
Status:
Grant
Type:
Utility
Filling date:
27 Jul 2017
Issue date:
24 May 2022